P2.12-06 Treatment Patterns and Clinical Outcomes in Patients with EGFR-mutant NSCLC after Progression on First-Line Osimertinib
Robinson N, Zhan P, Udelsman B, Boffa D, Goldberg S. P2.12-06 Treatment Patterns and Clinical Outcomes in Patients with EGFR-mutant NSCLC after Progression on First-Line Osimertinib. Journal Of Thoracic Oncology 2023, 18: s364. DOI: 10.1016/j.jtho.2023.09.641.Peer-Reviewed Original Research